Cardiac Implant Articles & Analysis: Older
32 news found
Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has joined the Amazon Web Services (AWS) Independent Software Vendor (ISV) Accelerate Program, a co-sell program for AWS partners that provide software solutions that run on or integrate with AWS. ...
With a WATCHMAN implant, patients no longer require a blood thinner to decrease their risk of stroke, dramatically reducing their risk of bleeding. To complete a WATCHMAN implant, cardiologists rely on X-ray-based 2D imaging with contrast dye to identify cardiac structures and guide implant of the cardiac ...
Location: Caesarea, Israel and Agoura California V-Wave Ltd., a cardiovascular device company developing proprietary, minimally invasive interatrial shunt devicesfor treating patients with severe symptomatic heart failure (HF) and pulmonary arterial hypertension (PAH), announced today that it has successfully closed all remaining tranches of the Series C extension totaling $98M. The financing ...
Many patients with heart failure require cardiac resynchronization therapy (CRT), which uses lead-based cardiac pacing devices to coordinate the beating of the left and right sides of the heart. ...
Dr Steinhaus has extensive clinical and business experience in cardiac rhythm management, including performing numerous clinical studies in implantable cardiac devices and leads. ...
” LBBAP pacing has been proposed as a strategy to achieve physiological pacing by utilizing the heart’s native conduction system, allowing faster left ventricular activation time.1 LBBAP has potential applications in both traditional bradycardia pacing and as an alternative approach to Cardiac Resynchronization Therapy (CRT).2 Until now, LBBAP has required use of a ...
During his 30-year career, he has acquired a unique expertise in implantable cardiac devices. Former VP RAQACA of CardiAQ Valve Technologies, a transcatheter valve start-up acquired by Edwards Lifesciences for $350 million, he has also developed an extensive knowledge of cardiac assist devices (first at Arrow, then at Abbott as a consultant) and ...
ByCorWave
Professor Pascal Leprince, Head of Cardiac and Thoracic Surgery at the AP-HP Pitié-Salpêtrière Hospital and Professor at the Sorbonne University Faculty of Medicine, commented, “The recent ESAO communication by CorWave on chronic animal trialsshows this new generation pump is very promising and will continue to move the LVAD field toward ...
ByCorWave
WiSE Technology enables cardiac pacing of the left ventricle with a novel cardiac implant that is roughly the size of a large grain of rice. ...
The implant was performed at UofL Health – Jewish Hospital by University of Louisville physicians within the framework of the U.S. ...
ByCarmat
The data demonstrated that BackBeat Cardiac Neuromodulation Therapy™ (CNT™), a programmable and adjustable bioelectronic therapy delivered via an active implantable cardiac pulse generator, significantly reduced 24-hour ambulatory systolic blood pressure (aSBP) in patients with persistent hypertension and a clinical indication for a ...
” VT and ventricular fibrillation are important causes of sudden cardiac death, accounting for as many as 450,000 annual deaths in the US alone. Implantable cardiac defibrillators reduce the incidence of death in patients with arrhythmias, but are not curative, and can contribute to reduced quality of life in patients with recurring ...
The Alleviant System is a novel transcatheter device for the creation of a therapeutic interatrial shunt without a permanent cardiac implant. Results were presented at the American College of Cardiology Scientific Session (ACC.21) and at the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EuroPCR 2021) by Colin Barker, MD, ...
Gordon Ho, at American College of Cardiology 2021 and the Taiwan Heart Rhythm Society 2021 (THRS), the research won first prize in the “Clinical - Ventricular Arrhythmias/Cardiac Implanted Electronic Device” category at THRS. As stated at the ACC and THRS conferences, the study concluded that the simplified, non-invasive workflow, involving ...
EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that Professor Pascal Defaye, Head of Rhythmology and Cardiac Stimulation Unit, CHU de Grenoble-Alpes, France, performed the world’s first successful Leadless Left Bundle Branch Area Pacing (LBBAP) implant performed ...
CardiacSense’s medical watch CE Mark enables continuous, long-term, accurate and comfortable patient monitoring without the need to implant invasive cardiac monitors – a prevalent practice for patients experiencing arrhythmias. ...
Alleviant Medical Inc., a privately-held medical device company, today announced that the US Food and Drug Administration (FDA) has granted the company a Breakthrough Device designation for its transcatheter technology. The technology offers a no-implant interatrial shunt therapy for patients suffering from heart failure with preserved (HFpEF) and mid-range ejection fraction ...
V-Wave Ltd., a cardiovascular device company developing proprietary, minimally invasive interatrial shunt devices for treating patients with severe symptomatic heart failure (HF) and pulmonary arterial hypertension (PAH), announced today that it has closed a Series C extension of up to $98M. The financing assures capital to complete clinical trials for the Ventura® Interatrial Shunt for the ...
After neurosurgery, Endomedix plans to target hemostasis indications for cardiac pacemaker and implanted defibrillator procedures. As an example of the potential scope of the technology, Endomedix has recently entered into a Cooperative Research And Development Agreement (CRADA) with the US Army using PLEXimine to develop a treatment for Ocular Projectile ...
David is a highly effective R&D leader who has led numerous successful medical and consumer implantable and wearable devices. Most recently, David worked at Cambridge Consultants, where he developed systems ranging from physiology monitoring devices to robotic test systems. ...